Shukra Pharmaceuticals consolidated net profit rises 1158.25% in the June 2026 quarter

Sales rise 336.36% to Rs 23.52 crore
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.